Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» diabetes
diabetes
Mylan and Biocon Gain FDA Approval for Insulin Equivalent to Sanofi's Lantus
Motley Fool
Fri, 06/12/20 - 08:03 pm
FDA
Mylan
Biocon
Semglee
Sanofi
insulin
Lantus
diabetes
FDA Announces Five Companies Are Recalling Diabetes Drugs Over Carcinogen Concerns
BioSpace
Fri, 06/12/20 - 10:46 am
product recalls
FDA
diabetes
Apotex
Amneal
Marksans
Lupin
Teva Pharmaceutical
metformin
NDMA
Fractyl Seeks to Turn Diabetes On Its Ear with Revita DMR
Medical Devices and Diagnostics Industry
Thu, 06/11/20 - 12:13 pm
Fractyl Labs
diabetes
type 2 diabetes
Revita DMR
devices
Medtech
With $55M in new funding, Bigfoot Biomedical takes strides toward FDA submission
MedCity News
Thu, 06/4/20 - 12:44 pm
Bigfoot Biomedical
FDA
smart insulin
devices
diabetes
insulin
FDA asks 5 drugmakers to recall metformin products
Beckers Hospital Review
Tue, 06/2/20 - 10:17 am
FDA
diabetes
product recalls
NDMA
metformin
This Diabetes Company's Q1 Earnings Reflect the Resiliency of Its Business Model
Motley Fool
Mon, 06/1/20 - 10:34 am
Insulet
diabetes
devices
insulin pumps
earnings
FDA pushes metformin recalls for 5 drugmakers after carcinogen contamination
Fierce Pharma
Fri, 05/29/20 - 10:44 am
FDA
diabetes
NDMA
metformin
product recalls
Viacyte Adds $27M to Move Ahead Trio of Stem Cell Diabetes Treatments
Xconomy
Tue, 05/26/20 - 11:52 am
ViaCyte
diabetes
gene editing
stem cells
Biotech Kriya snags $80.5M to push gene therapy beyond rare disease
Fierce Biotech
Tue, 05/12/20 - 11:52 am
Kriya Therapeutics
gene therapy
diabetes
Shankar Ramaswamy
Why Diabetes Stock Insulet Jumped Nearly 21% in April
Motley Fool
Sun, 05/3/20 - 07:56 pm
Insulet
diabetes
devices
insulin pumps
Omnipod
To Help High-Risk COVID-19 Patients, AstraZeneca's Testing a Diabetes Treatment
Motley Fool
Thu, 04/23/20 - 09:09 pm
AstraZeneca
diabetes
Farxiga
COVID-19
Reversing diabetes with CRISPR and patient-derived stem cells
Fierce Biotech
Wed, 04/22/20 - 10:31 pm
diabetes
CRISPR
stem cells
Bayer’s big kidney disease readout approaches
EP Vantage
Tue, 04/21/20 - 12:27 pm
Bayer
finerenone
kidney disease
clinical trials
diabetes
diabetic kidney disease
Novo Nordisk expands 90-day free insulin program to workers affected by COVID-19
Fierce Pharma
Wed, 04/15/20 - 11:08 pm
Novo Nordisk
insulin
diabetes
COVID-19
Can a popular class of diabetes drugs that includes Merck's Januvia help treat COVID-19?
Fierce Biotech
Wed, 04/15/20 - 10:52 am
COVID-19
pandemic
Merck
Januvia
diabetes
Boehringer Ingelheim
Eli Lilly
Tradjenta
Eli Lilly lowers insulin costs as coronavirus crisis deepens
Yahoo/Reuters
Tue, 04/7/20 - 10:55 am
Eli Lilly
diabetes
insulin
drug pricing
COVID-19
Researchers Warn Possible Coronavirus Treatment Hydroxychloroquine May Be Toxic When Combined With Diabetes Drug
Forbes
Sun, 04/5/20 - 02:27 pm
hydroxychloroquine. metformin
diabetes
COVID-19
pancreatic cancer
AstraZeneca on expanding its diabetes research franchise
Pharmaforum
Fri, 04/3/20 - 11:17 am
AstraZeneca
diabetes
Biocon insulin operation gets FDA nod, paving way for approval of Lantus knockoff
Fierce Pharma
Thu, 04/2/20 - 11:58 pm
Biocon
insulin
diabetes
Lantus
Mylan
drug manufacturing
Lilly ad campaign in U.S. newspapers offers diabetes med help for patients affected by COVID-19 shutdowns
Fierce Pharma
Tue, 03/31/20 - 10:53 pm
Eli Lilly
drug ads
COVID-19
diabetes
Pages
« first
‹ previous
…
15
16
17
18
19
20
21
22
23
…
next ›
last »